Business · 31/03/1994Updated: 10/15/2026 · 1 min read
Solvay Pharmaceuticals et al.; Withdrawal of Approval of 24 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 24 abbreviated new drug applications (ANDA's) after receiving written notifications from their holders that the drug products were no longer marketed.
Original source language: Federal Register — Health and Human ServicesOpen original release →